Evaluating allogeneic chondroprogenitor manufacture under Good Manufacturing Practice (GMP) conditions. (2023)

First Author: Perry J
Attributed to:  Allogeneic Chondroprogenitor Therapy (Phase II) (ACT2) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract